Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway
Foteini Vasilopoulou, Christian Griñán‐Ferré, Sergio Rodríguez‐Arévalo, et al.
GeroScience (2020) Vol. 43, Iss. 2, pp. 965-983
Open Access | Times Cited: 16

Showing 16 citing articles:

Maternal exposure to deltamethrin during pregnancy and lactation impairs hippocampal learning and memory function of male offspring by ferroptosis
Shasha Huang, Wanqi Li, Dengke Wang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 290, pp. 117729-117729
Open Access | Times Cited: 2
Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties
Andrea Bagán, Alba López-Ruiz, Sònia Abás, et al.
Journal of Medicinal Chemistry (2025)
Open Access | Times Cited: 1
NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice
Júlia Companys‐Alemany, Andreea L. Turcu, Marion Schneider, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 26
The Role of Intravenous Anesthetics for Neuro: Protection or Toxicity?
Kaixin Wang, Yafeng Wang, Tianhao Zhang, et al.
Neuroscience Bulletin (2024)
Open Access | Times Cited: 4
Targeting CaN/NFAT in Alzheimer’s brain degeneration
Joanna Mackiewicz, Malwina Lisek, Tomasz Boczek
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Disease‐modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil
Foteini Vasilopoulou, Sergio Rodríguez‐Arévalo, Andrea Bagán, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 15, pp. 3017-3033
Open Access | Times Cited: 22
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
You‐Cui Wang, Xiaoqin Zhang, Fenghua Chen, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 2583-2586
Open Access | Times Cited: 18
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease
Sergio Rodríguez‐Arévalo, Andrea Bagán, Christian Griñán‐Ferré, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113540-113540
Open Access | Times Cited: 16
Heterocycle-Based Multicomponent Reactions in Drug Discovery: From Hit Finding to Rational Design
Pau Nadal Rodríguez, Ouldouz Ghashghaei, Andrea Bagán, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1488-1488
Open Access | Times Cited: 9
Sex differences in the antidepressant-like response and molecular events induced by the imidazoline-2 receptor agonist CR4056 in rats
Elena Hernández‐Hernández, Sandra Ledesma‐Corvi, Fernando Yáñez, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173527-173527
Open Access | Times Cited: 4
Astrocyte Reactivity in Alzheimer’s Disease: Therapeutic Opportunities to Promote Repair
Nazanin Mirzaei, Nicola Davis, Tsz Wing Chau, et al.
Current Alzheimer Research (2021) Vol. 19, Iss. 1, pp. 1-15
Open Access | Times Cited: 8
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Andrea Bagán, Sergio Rodríguez‐Arévalo, Teresa Taboada, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2381-2381
Open Access | Times Cited: 3
Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I2 Receptor Ligand B06
Andrea Bagán, José Á. Morales-García, Christian Griñán‐Ferré, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5408-5408
Open Access | Times Cited: 4
Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer’s disease mouse model : A Comparative study with donepezil
Fotini Vasilopoulou, Sergio Rodríguez‐Arévalo, Andrea Bagán, et al.
Authorea (Authorea) (2020)
Open Access | Times Cited: 5
Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands
Andrea Bagán, Sònia Abás, Judith Palà‐Pujadas, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106935-106935
Open Access | Times Cited: 1
Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model
Foteini Vasilopoulou, Carmen Escolano, Mercé Pallás, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1315-1315
Open Access | Times Cited: 1
Page 1

Scroll to top